Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Sales (2020 - 2025)

Historic Return on Sales for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 0.21%.

  • Harmony Biosciences Holdings' Return on Sales fell 400.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.16% for FY2024, which is 300.0% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Return on Sales of 0.21% as of Q3 2025, which was down 400.0% from 0.2% recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Return on Sales ranged from a high of 0.75% in Q3 2022 and a low of 0.12% during Q3 2021
  • Over the past 5 years, Harmony Biosciences Holdings' median Return on Sales value was 0.22% (recorded in 2022), while the average stood at 0.22%.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Return on Sales skyrocketed by 20700bps in 2021 and then plummeted by -5100bps in 2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Return on Sales (Quarter) stood at 0.21% in 2021, then surged by 81bps to 0.38% in 2022, then tumbled by -79bps to 0.08% in 2023, then skyrocketed by 36bps to 0.11% in 2024, then skyrocketed by 99bps to 0.21% in 2025.
  • Its last three reported values are 0.21% in Q3 2025, 0.2% for Q2 2025, and 0.25% during Q1 2025.